Tuberculosis Medications Program - Minnesota Dept. of Health

Tuberculosis Medications Program

NOTE: Due to budget restrictions the MDH TB Program will be making changes to the eligibility criteria of the TB Medications Program. These changes will go into effect by June 30, 2019. Please watch our website for the changes to be posted when finalized. Thank you for your patience as we figure out how to better sustain our limited resources.

The Minnesota Department of Health (MDH) Tuberculosis (TB) Prevention and Control Program's medication program serves to eliminate financial barriers to medication for the treatment of latent TB infection (LTBI) or active TB disease for state residents. When possible, the program coordinates with a contracted pharmacy to bill individuals' prescription insurance while covering related co-pays, so that TB medications are always at no cost to the patients.

Treatment regimens using medications supplied by MDH must follow the Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis, CID for treatment of LTBI or treatment of active TB disease.

On this page:
Medications for latent TB infection
Medication for active TB disease
Letters

Medication for latent TB infection

  1. The provider should complete and submit the request form to MDH:
    • Request for Latent TB Infection (LTBI) Medications (PDF)
      Fax completed form to: 651-201-5500
      or mail to:
      TB Medications Coordinator
      MDH TB Prevention and Control Program
      Minnesota Department of Health
      P.O. Box 64975
      St. Paul, MN 55164-0975
    • Patients prescribed 12-week INH-RPT regimen for treatment of LTBI must meet eligibility criteria of being > 2 years of age and contact to active disease within 2 years; or > 2 years of age with medical predictive risk factor(s) for developing active disease; or > 2 years of age with social circumstances that make adherence and completion of longer regimens unlikely.
    • Forms that are incomplete, or not consistent with national LTBI treatment guidelines (PDF), will be delayed until resolved.

  2. Through our contracted pharmacy, MDH ships the patient's first month supply of LTBI medication within 5 – 7 business days, to the designated health care professional, licensed to administer medications.

  3. Complete the form that was included with the first shipment.
    • LTBI Medication Start Date Verification Form (PDF)
      Fax completed form to: 651-201-5500
      or mail to:
      TB Medications Coordinator
      MDH TB Prevention and Control Program
      Minnesota Department of Health
      P.O. Box 64975
      St. Paul, MN 55164-0975
    • Upon receiving this verification, MDH will ship monthly refills until the order is filled.
    • If treatment is discontinued for any reason or if the patient is lost to follow-up, please contact MDH at 651-201-5414 ASAP to stop shipments.

  4. The health care professional that receives medication shipments is responsible for monitoring the patient for adverse drug reactions and adherence to the regimen. The timing and type of monitoring activities should be done according to CDC guidelines for each regimen.  

More about LTBI medications

  • TB Basics
    Fact sheets for patients, including fact sheets on LTBI treatment and specific LTBI medications.

Medication for active TB disease

  1. To request medications for treatment of active TB disease, the provider should contact the MDH TB Nurse Case Manager at 651-201-5414 or 1-877-676-5414.

  2. The provider will be asked to provide pertinent clinical and demographic information, a copy of the prescription(s), patient prescription insurance information.
    Request for Active Tuberculosis Medications (Presumed/Confirmed) (PDF)

  3. Medications will be sent monthly to the designated clinic, local public health agency, or other provider licensed to administer medications.

  4. If a patient being treated for active TB disease stops therapy, fails to pick up medications, or if treatment is discontinued, please contact the MDH TB Nurse Case Manager immediately.

Letters

Updated Thursday, 18-Apr-2019 11:06:50 CDT